The flood of genomic data is revolutionizing our approach to understanding normal cellular processes and the mechanisms of disease. This has driven the transformation of genomics research into an information science where sophisticated computational methods are critical to the integration and analysis of multiple types of data to inform hypotheses and drive research. Since 2004 GenePattern has provided the biomedical research community with a comprehensive environment for genomic analysis. Through GenePattern we share advanced mathematical methods and computational algorithms in a user-friendly, freely available software package. The power of the software is that it is accessible to a broad community of users, provides a library of analytic and visualization modules that can interoperate, supports the rapid development and dissemination of new methods, and supports reproducibility of computational research. The substantial impact of the software can be gauged by its citations and large user base. However, for many biomedical researchers the challenge still remains to know which methods to use for their study, how to use them correctly, and how to get the kind of guidance sitting side by side with an expert would provide. The goal of our specific aims for this competitive renewal is to address this critical nee through a new approach to how GenePattern delivers its capabilities to the entire research community.
Aim 1. Develop comprehensive GenePattern-Solutions for genomic research. These Solutions represent a new paradigm by providing analysis solutions rather than simply a collection of tools. We will formulate and implement Solutions tied to scientific scenarios and tasks and deliver them to our users through a new interactive, guided user interface.
Aim 2. Enhance GenePattern's interactivity, flexibility, and overall user experience. We will provide closer connectivity between visualization and analysis, add support for mobile devices, and further lower the barrier for other resources to leverage GenePattern's capabilities.
Aim 3. Support and grow the GenePattern user community. Importantly, we will place greater emphasis on open source development and address the high performance computing demands of current analysis approaches through a strategic alliance with Indiana University's (IU) National Center for Genome Analysis Support (NCGAS). Finally we will continue to provide and enhance our outreach activities, user support, training, and documentation. Our progress over our previous funding period, close involvement in genomic research, extensive software engineering experience, and significant user base make us well poised to carry out the aims of this proposal.
The GenePattern genomic analysis environment puts sophisticated computational methods within the reach of all biomedical researchers and, through the analysis of the increasing amount of available genomic data, is used to address a variety of problems at the forefront of biomedical research including patient diagnosis and prognosis, identification of new drug targets, and understanding biological mechanisms. The work in this project will improve the GenePattern software by developing GenePattern-Solutions. This new approach provides analysis solutions, rather than simply a collection of tools, to make GenePattern better able to support the broadest range of biomedical researchers tackling the important questions facing them today.
|Reich, Michael; Tabor, Thorin; Liefeld, Ted et al. (2017) The GenePattern Notebook Environment. Cell Syst 5:149-151.e1|
|Silterra, Jacob; Gillette, Michael A; Lanaspa, Miguel et al. (2017) Transcriptional Categorization of the Etiology of Pneumonia Syndrome in Pediatric Patients in Malaria-Endemic Areas. J Infect Dis 215:312-320|
|Zhu, Xiaodong; Girardo, David; Govek, Eve-Ellen et al. (2016) Role of Tet1/3 Genes and Chromatin Remodeling Genes in Cerebellar Circuit Formation. Neuron 89:100-12|
|Durand, Neva C; Robinson, James T; Shamim, Muhammad S et al. (2016) Juicebox Provides a Visualization System for Hi-C Contact Maps with Unlimited Zoom. Cell Syst 3:99-101|
|Hanaford, Allison R; Archer, Tenley C; Price, Antoinette et al. (2016) DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets. Clin Cancer Res 22:3903-14|
|Kim, Jong Wook; Botvinnik, Olga B; Abudayyeh, Omar et al. (2016) Characterizing genomic alterations in cancer by complementary functional associations. Nat Biotechnol 34:539-46|
|Godec, Jernej; Tan, Yan; Liberzon, Arthur et al. (2016) Compendium of Immune Signatures Identifies Conserved and Species-Specific Biology in Response to Inflammation. Immunity 44:194-206|
|Liberzon, Arthur; Birger, Chet; Thorvaldsdóttir, Helga et al. (2015) The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst 1:417-425|
|Stewart, Michelle L; Tamayo, Pablo; Wilson, Andrew J et al. (2015) KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine. Cancer Res 75:2897-906|
|Wilson, Frederick H; Johannessen, Cory M; Piccioni, Federica et al. (2015) A functional landscape of resistance to ALK inhibition in lung cancer. Cancer Cell 27:397-408|
Showing the most recent 10 out of 25 publications